Wei-Sheng Huang, Acton US
Wei-Sheng Huang, Acton, MA US
Patent application number | Description | Published |
---|---|---|
20090149471 | Monocyclic Heterocyclic Compounds - This invention relates to compounds of the general formula: | 06-11-2009 |
20090156596 | Unsaturated Heterocyclic Derivatives - This invention relates to compounds of the general formula: | 06-18-2009 |
20090176781 | Acetylenic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 07-09-2009 |
20110288078 | PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS - This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use. | 11-24-2011 |
20120135986 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 05-31-2012 |
20120178716 | Unsaturated Heterocyclic Derivatives - This invention relates to compounds of the general formula: | 07-12-2012 |
20120202776 | PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS - The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use. | 08-09-2012 |
20120316135 | Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers - The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: | 12-13-2012 |
20120316137 | Methods and Compositions for Treating Cancer - The invention features methods, kits, and pharmaceutical compositions for treating cancer using 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)-methyl)-3-(trifluoromethyl)phenyl)benzamide. | 12-13-2012 |
20130005738 | Monocyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 01-03-2013 |
20130018046 | Acetylenic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 01-17-2013 |
20130178622 | Methods and Compositions for Treating Cancer - The invention features methods, kits, and pharmaceutical compositions for treating cancer using 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)-methyl)-3-(trifluoromethyl)phenyl)benzamide. | 07-11-2013 |
20130196979 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 08-01-2013 |
20130225527 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 08-29-2013 |
20130225528 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 08-29-2013 |
20130231337 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 09-05-2013 |
20140066406 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 03-06-2014 |
20140288082 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 09-25-2014 |
20140364423 | Pyrazinopyrazines and Derivatives as Kinase Inhibitors - This invention relates to compounds of the general formula: | 12-11-2014 |